AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Ghielmini, M Van der Bosch, S Bosshard, M Pampallona, S Gabutti, L Egger, HP Kiess, M Cavalli, F Sessa, C
Citation: M. Ghielmini et al., Phase I-II study of escalating doses of amifostine combined with high-dosecyclophosphamide, CANC CHEMOT, 47(6), 2001, pp. 532-536

Authors: Rauch, DP Maurer, CA Aebi, S Pampallona, S Friess, H Ludwig, CU Buchler, MW Borner, MM
Citation: Dp. Rauch et al., Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer, ONCOL-BASEL, 60(1), 2001, pp. 43-48

Authors: Gervaz, P Blanchard, A Pampallona, S Mach, JP Fontolliet, C Gillet, M
Citation: P. Gervaz et al., Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases, EURO J SURG, 166(7), 2000, pp. 557-561

Authors: Spataro, V Kovacsovics, T Bach, S Pampallona, S Schapira, M Cavalli, F
Citation: V. Spataro et al., Acute myeloid leukemia in the elderly: Results of an individualized approach in two centres, LEUK LYMPH, 39(5-6), 2000, pp. 521-530

Authors: Ghielmini, M Marangoni, G Pampallona, S Tamasy, P Cavalli, F
Citation: M. Ghielmini et al., Morphologic, immunophenotypic and in vitro growth characteristics of bloodand bone marrow associated with stem cell mobilisation in patients with lymphoma, LEUK LYMPH, 38(3-4), 2000, pp. 351-361

Authors: Bouzourene, H Gervaz, P Cerottini, JP Benhattar, J Chaubert, P Saraga, E Pampallona, S Bosman, FT Givel, JC
Citation: H. Bouzourene et al., p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer, EUR J CANC, 36(8), 2000, pp. 1008-1015

Authors: von Rohr, E Pampallona, S van Wegberg, B Cerny, T Hurny, C Bernhard, J Helwig, S Heusser, P
Citation: E. Von Rohr et al., Attitudes and beliefs towards disease and treatment in patients with advanced cancer using anthroposophical medicine, ONKOLOGIE, 23(6), 2000, pp. 558-563

Authors: Delaloye, JF Pampallona, S Coucke, PA Megalo, A De Grandi, P
Citation: Jf. Delaloye et al., Effect of grade on disease-free survival and overall survival in FIGO stage I adenocarcinoma of the endometrium, EUR J OB GY, 88(1), 2000, pp. 75-80

Authors: von Rohr, E Pampallona, S van Wegbeg, B Hurny, C Bernhard, J Heusser, P Cerny, T
Citation: E. Von Rohr et al., Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer, SCHW MED WO, 130(34), 2000, pp. 1173-1184

Authors: Loutan, L Bollini, P Pampallona, S De Haan, DB Gariazzo, F
Citation: L. Loutan et al., Impact of trauma and torture on asylum-seekers, EUR J PUB H, 9(2), 1999, pp. 93-96

Authors: Cerottini, JP Caplin, S Pampallona, S Givel, JC
Citation: Jp. Cerottini et al., Prognostic factors in colorectal cancer, ONCOL REP, 6(2), 1999, pp. 409-414

Authors: Ghielmini, M Zappa, F Menafoglio, A Caoduro, L Pampallona, S Gallino, A
Citation: M. Ghielmini et al., The high-dose sequential (Milan) chemotherapy PBSC transplantation regimenfor patients with lymphoma is not cardiotoxic, ANN ONCOL, 10(5), 1999, pp. 533-537

Authors: Ghielmini, M Bosshard, G Pampallona, S Genini, D Bernier, J Sessa, C
Citation: M. Ghielmini et al., Differential toxicity of anticancer drugs on late (GM-CFC) and early (LTC-IC) hemopoietic progenitors in vitro, CELL BIOL T, 15(6), 1999, pp. 395-404

Authors: Leyvraz, S Perey, L Rosti, G Lange, A Pampallona, S Peters, R Humblet, Y Bosquee, L Pasini, F Marangolo, M
Citation: S. Leyvraz et al., Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European group for blood and marrow transplantation, J CL ONCOL, 17(11), 1999, pp. 3531-3539

Authors: Koutaissoff, S Wellmann, D Coucke, P Ozsahin, M Pampallona, S Mirimanoff, RO
Citation: S. Koutaissoff et al., Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): Results of a phaseII study for patients ineligible for combination radiochemotherapy, INT J RAD O, 45(5), 1999, pp. 1151-1156

Authors: Loutan, L Farinelli, T Pampallona, S
Citation: L. Loutan et al., Medical interpreters have feelings too, SOZ PRAVENT, 44(6), 1999, pp. 280-282

Authors: Muscettola, G Barbato, G Pampallona, S Casiello, M Bollini, P
Citation: G. Muscettola et al., Extrapyramidal syndromes in neuroleptic-treated patients: Prevalence, riskfactors, and association with tardive dyskinesia, J CL PSYCH, 19(3), 1999, pp. 203-208

Authors: Bollini, P Pampallona, S Tibaldi, G Kupelnick, B Munizza, C
Citation: P. Bollini et al., Effectiveness of antidepressants - Meta-analysis of dose-effect relationships in randomised clinical trials, BR J PSYCHI, 174, 1999, pp. 297-303

Authors: Ghielmini, M Pagani, O de Jong, J Pampallona, S Conti, A Maestroni, G Sessa, C Cavalli, F
Citation: M. Ghielmini et al., Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer, BR J CANC, 80(7), 1999, pp. 1058-1061

Authors: Bollini, P Pampallona, S O'Rourke, T Jones, W Truong, TB Nguyen, HP Bang, LC An, DQ Keane, VP Siem, H Gushulak, B
Citation: P. Bollini et al., Outcome of second-line tuberculosis treatment in migrants from Vietnam, TR MED I H, 3(12), 1998, pp. 975-980

Authors: Perey, L Peters, R Pampallona, S Schneider, P Gross, N Leyvraz, S
Citation: L. Perey et al., Extensive phenotypic analysis of CD34 subsets in successive collections ofmobilized peripheral blood progenitors, BR J HAEM, 103(3), 1998, pp. 618-629
Risultati: 1-21 |